Oric Pharmaceuticals IncNASDAQ:ORIC
- LAST PRICE9.6100
- TODAY'S CHANGE (%)0.0700 (0.7338%)
- Bid / Lots3.8500/ 2
- Ask / Lots9.8500/ 1
- Open / Previous Close9.7400 / 9.5400
- Day Range
- 52 Week Range
- Volume202,037
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ORIC |
|---|---|---|
| 09:32 ET | 4670 | 9.77 |
| 09:34 ET | 676 | 9.74 |
| 09:39 ET | 7713 | 9.7829 |
| 09:45 ET | 100 | 9.8 |
| 09:52 ET | 227 | 9.74 |
| 09:54 ET | 1755 | 9.7 |
| 09:56 ET | 200 | 9.625 |
| 09:57 ET | 200 | 9.66 |
| 10:03 ET | 200 | 9.64 |
| 10:10 ET | 500 | 9.7 |
| 10:14 ET | 1397 | 9.67 |
| 10:15 ET | 300 | 9.7 |
| 10:17 ET | 100 | 9.7 |
| 10:19 ET | 700 | 9.69 |
| 10:21 ET | 860 | 9.67 |
| 10:26 ET | 290 | 9.56 |
| 10:28 ET | 231 | 9.6 |
| 10:32 ET | 100 | 9.59 |
| 10:33 ET | 100 | 9.55 |
| 10:35 ET | 200 | 9.58 |
| 10:37 ET | 173 | 9.582 |
| 10:42 ET | 200 | 9.57 |
| 10:44 ET | 100 | 9.58 |
| 10:46 ET | 200 | 9.545 |
| 10:48 ET | 200 | 9.56 |
| 10:51 ET | 100 | 9.585 |
| 10:55 ET | 300 | 9.615 |
| 10:57 ET | 500 | 9.62 |
| 11:00 ET | 100 | 9.615 |
| 11:02 ET | 400 | 9.66 |
| 11:04 ET | 484 | 9.64 |
| 11:08 ET | 200 | 9.64 |
| 11:09 ET | 400 | 9.63 |
| 11:13 ET | 1798 | 9.605 |
| 11:15 ET | 271 | 9.55 |
| 11:18 ET | 200 | 9.501 |
| 11:20 ET | 750 | 9.53 |
| 11:22 ET | 400 | 9.48 |
| 11:24 ET | 1360 | 9.43 |
| 11:29 ET | 100 | 9.44 |
| 11:31 ET | 100 | 9.48 |
| 11:36 ET | 800 | 9.46 |
| 11:38 ET | 100 | 9.49 |
| 11:40 ET | 100 | 9.47 |
| 11:42 ET | 1412 | 9.48 |
| 11:44 ET | 200 | 9.51 |
| 11:45 ET | 100 | 9.515 |
| 11:47 ET | 379 | 9.48 |
| 11:49 ET | 300 | 9.49 |
| 11:51 ET | 100 | 9.485 |
| 11:54 ET | 100 | 9.49 |
| 11:56 ET | 400 | 9.505 |
| 11:58 ET | 100 | 9.52 |
| 12:00 ET | 100 | 9.54 |
| 12:02 ET | 200 | 9.535 |
| 12:03 ET | 1100 | 9.47 |
| 12:05 ET | 200 | 9.51 |
| 12:07 ET | 100 | 9.51 |
| 12:09 ET | 100 | 9.53 |
| 12:12 ET | 300 | 9.505 |
| 12:14 ET | 300 | 9.52 |
| 12:16 ET | 200 | 9.54 |
| 12:20 ET | 100 | 9.54 |
| 12:21 ET | 422 | 9.52 |
| 12:23 ET | 500 | 9.54 |
| 12:25 ET | 1100 | 9.53 |
| 12:27 ET | 400 | 9.52 |
| 12:30 ET | 100 | 9.54 |
| 12:34 ET | 200 | 9.53 |
| 12:38 ET | 1200 | 9.54 |
| 12:41 ET | 804 | 9.545 |
| 12:43 ET | 754 | 9.54 |
| 12:45 ET | 266 | 9.5449 |
| 12:48 ET | 800 | 9.57 |
| 12:52 ET | 200 | 9.575 |
| 12:54 ET | 606 | 9.57 |
| 12:56 ET | 200 | 9.57 |
| 12:57 ET | 100 | 9.58 |
| 01:01 ET | 100 | 9.58 |
| 01:03 ET | 543 | 9.55 |
| 01:06 ET | 1700 | 9.61 |
| 01:08 ET | 900 | 9.59 |
| 01:10 ET | 400 | 9.59 |
| 01:12 ET | 400 | 9.6 |
| 01:14 ET | 200 | 9.595 |
| 01:15 ET | 100 | 9.61 |
| 01:17 ET | 100 | 9.61 |
| 01:19 ET | 5335 | 9.63 |
| 01:21 ET | 3891 | 9.7 |
| 01:24 ET | 100 | 9.66 |
| 01:26 ET | 100 | 9.67 |
| 01:28 ET | 100 | 9.655 |
| 01:30 ET | 100 | 9.67 |
| 01:32 ET | 200 | 9.64 |
| 01:33 ET | 100 | 9.65 |
| 01:35 ET | 300 | 9.68 |
| 01:39 ET | 200 | 9.67 |
| 01:42 ET | 800 | 9.66 |
| 01:44 ET | 795 | 9.68 |
| 01:46 ET | 100 | 9.68 |
| 01:50 ET | 100 | 9.67 |
| 01:51 ET | 400 | 9.62 |
| 01:53 ET | 600 | 9.59 |
| 02:00 ET | 100 | 9.59 |
| 02:20 ET | 100 | 9.55 |
| 02:22 ET | 1200 | 9.545 |
| 02:33 ET | 1052 | 9.563651 |
| 02:38 ET | 100 | 9.58 |
| 02:40 ET | 100 | 9.58 |
| 02:42 ET | 1645 | 9.588 |
| 02:49 ET | 200 | 9.57 |
| 02:51 ET | 202 | 9.625 |
| 02:56 ET | 100 | 9.635 |
| 02:58 ET | 200 | 9.66 |
| 03:02 ET | 600 | 9.65 |
| 03:03 ET | 200 | 9.645 |
| 03:09 ET | 3111 | 9.65 |
| 03:12 ET | 100 | 9.65 |
| 03:16 ET | 407 | 9.64 |
| 03:20 ET | 300 | 9.65 |
| 03:21 ET | 100 | 9.66 |
| 03:23 ET | 800 | 9.67 |
| 03:27 ET | 528 | 9.63 |
| 03:30 ET | 700 | 9.65 |
| 03:32 ET | 524 | 9.6342 |
| 03:34 ET | 250 | 9.638 |
| 03:36 ET | 444 | 9.655 |
| 03:38 ET | 100 | 9.65 |
| 03:39 ET | 400 | 9.67 |
| 03:41 ET | 651 | 9.68 |
| 03:43 ET | 2307 | 9.67 |
| 03:45 ET | 400 | 9.675 |
| 03:48 ET | 700 | 9.67 |
| 03:52 ET | 600 | 9.66 |
| 03:54 ET | 8674 | 9.65 |
| 03:56 ET | 9279 | 9.65 |
| 03:57 ET | 1817 | 9.63 |
| 03:59 ET | 45693 | 9.61 |
Yesterday
Sep 18, 2024
DJ Oric Pharmaceuticals Price Target Maintained With a $21.00/Share by HC Wainwright & Co., from 1:42PM ET on Wednesday Sep 18, 2024 by Dow Jones
1:42PM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 10, 2024
DJ Oric Pharmaceuticals Price Target Maintained With a $20.00/Share by Wedbush, from 9:08AM ET on Tuesday Sep 10, 2024 by Dow Jones
9:08AM ET on Tuesday Sep 10, 2024 by Dow Jones
Sep 6, 2024
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4), from 4:30PM ET on Friday Sep 06, 2024 by Dow Jones
4:30PM ET on Friday Sep 06, 2024 by Dow JonesDJ Oric Pharmaceuticals Initiated at Buy by Stifel, from 11:39AM ET on Friday Sep 06, 2024 by Dow Jones
11:39AM ET on Friday Sep 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Oric Pharmaceuticals Inc | 677.9M | -5.5x | --- |
Tourmaline Bio Inc | 685.4M | -10.5x | --- |
Astria Therapeutics Inc | 669.8M | -5.2x | --- |
Mineralys Therapeutics Inc | 690.2M | -5.1x | --- |
Annexon Inc | 664.6M | -5.2x | --- |
Olema Pharmaceuticals Inc | 664.3M | -5.6x | --- |
Company Information
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in improving patients' lives by overcoming resistance in cancer. It is developing a pipeline of clinical and discovery stage therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology and key tumor dependencies. Its clinical-stage product candidates include ORIC-114, a brain penetrant inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations, being developed across multiple genetically defined cancers, ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens.
Contact Information
- Headquarters
- 240 E. Grand Ave, 2nd FloorSOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-388-5600
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Richard Heyman
- President, Chief Executive Officer, Director
- Jacob Chacko
- Chief Financial Officer
- Dominic Piscitelli
- Chief Medical Officer
- Pratik Multani
- Independent Director
- Mardi Dier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $677.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.12 |
EPS | $-1.76 |
Book Value | $4.08 |
P/E Ratio | -5.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
